BPC
ASPN icon

Bryce Point Capital’s Aspen Aerogels ASPN Stock Holding History

Bryce Point Capital’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-97,059
Closed -$749K – 186
2025
Q1 		$749K Sell
97,059
-23,114
-19% -$223K 0.56% 112
2024
Q4 		$1.43M Buy
+120,173
New +$2.05M 0.41% 86

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Bryce Point Capital's ASPN Position: Q2 2025 in Review

Bryce Point Capital sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 97,059 shares — an estimated $749K sold.

Bryce Point Capital first reported a position in ASPN in Q4 2024 and held it in 2 quarters. The position peaked at $1.43M in Q4 2024. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Bryce Point Capital reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Bryce Point Capital sold 97,059 Aspen Aerogels shares in Q2 2025, an estimated $749K.
  • Bryce Point Capital first reported a position in Aspen Aerogels in Q4 2024 and held it in 2 quarters.
  • Bryce Point Capital's Aspen Aerogels position peaked at $1.43M in Q4 2024.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Bryce Point Capital's 13F filing for Q2 2025, filed 5 Aug 2025.